2005
DOI: 10.3748/wjg.v11.i20.3151
|View full text |Cite
|
Sign up to set email alerts
|

An uncommon clinical presentation of retroperitoneal non-Hodgkin lymphoma successfully treated with chemotherapy: A case report

Abstract: We report the case of a patient affected by an extra-nodal non-Hodgkin lymphoma presenting as a unique, large retroperitoneal mass with an unusual clinical presentation mimicking gastric peptic or neoplastic disease. The patient was successfully treated with a first generation therapy, CHOP modified regimen (cyclophosphamide 600 mg/m2 intravenously on d 1, epirubicin 55 mg/m2 intravenously on d 1, vincristine 1.2 mg/m2 intravenously on d 1, prednisone 60 mg/m2 on d 1-5), and a complete response was achieved. T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0
1

Year Published

2006
2006
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 26 publications
0
10
0
1
Order By: Relevance
“… 1 Although lymphomas are considered to be one of the most common malignancies of the retro peritoneum, this location has been very rarely reported as the primary site. 2 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“… 1 Although lymphomas are considered to be one of the most common malignancies of the retro peritoneum, this location has been very rarely reported as the primary site. 2 …”
Section: Discussionmentioning
confidence: 99%
“…The poly-chemotherapy with CHOP represents the standard chemotherapy regimen for NHL treatment with good outcome, and few and acceptable side-effects. 2 New strategies with retuximab, a chimerical anti CD20 IgG1 monoclonal antibody which is a cell surface protein that occurs almost exclusively in mature B-cells, are used to improve the prognosis of these patients. 5 The prognosis has improved in recent years owing to the development of various aggressive chemotherapeutic regimens depending on the histological type, stage and age of each patient.…”
Section: Discussionmentioning
confidence: 99%
“…However, NHL rarely presents with a retroperitoneal or pelvic mass; during post-mortem studies of NHL patients an incident of less than 1% incidence was noted (7). Due to the uncommon anatomical location, the diagnosis and subsequent management of these patients tend to be difficult.…”
Section: Discussionmentioning
confidence: 99%
“…El compromiso extranodal se da en el 30-50% de los casos entre ellos en el tracto gastrointestinal produciendo anemia; pulmonar en la forma de nódulos; óseo causando dolor y en el sistema nervioso central (22)(23)(24)(25). Está descrito que puede producir reacción leucemoide neutrofílica como síndrome paraneoplásico (10,12 [16][17][18][19][20] .…”
Section: Masa Retroperitonealunclassified